BioCentury
ARTICLE | Financial News

Concert raises $84 million in IPO

February 14, 2014 1:23 AM UTC

Concert Pharmaceuticals Inc. (NASDAQ:CNCE) raised $84 million in an IPO through the sale of a bumped-up number of shares at the high end of its proposed range. The company sold 6 million shares at $14, valuing the company at $241.1 million. Earlier this month, Concert said it planned to sell 5 million shares at $12-$14. UBS; Wells Fargo; JMP Securities; and Roth Capital Markets are underwriters. Concert gained $0.18 to $14.18 on its first day of trading Thursday. ...